ReviewPharmacological research2022

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment.

Katherine O Kopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.